Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
G-Protein Coupled Receptors Market Growth From $3.63 Billion In 2026 To $4.76 Billion By 2030 At A CAGR Of 7%
The market for G-protein coupled receptors has experienced robust expansion over past years, projecting an increase from $3.4 billion in 2025 to $3.63 billion in 2026, which represents a compound annual growth rate (CAGR) of 6.8%. This expansion during the preceding period was driven by factors including increased research into neurotransmitters, progress in receptor biology, a surge in pharmaceutical research and development, advancements in cell line development, and innovations in assay technologies.
The global market for g-protein coupled receptors is poised for considerable expansion over the coming years, projected to reach a valuation of $4.77 billion by 2030, reflecting a compound annual growth rate of 7.0%. This anticipated growth trajectory is largely influenced by escalating requirements for precise drug targeting, advancements in AI-powered drug discovery methodologies, a burgeoning biologics pipeline, ongoing efforts in receptor deorphanization research, and increased investments directed towards translational research initiatives. Key developments expected to shape the market during this forecast period encompass the increasing adoption of GPCR targets within the drug discovery landscape, the expansion of high-throughput screening capabilities, a heightened emphasis on the investigation of orphan receptors, the advancement of cell-based assay technologies, and a growing trend of collaboration between academic institutions and pharmaceutical companies.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11976&type=smp
G-Protein Coupled Receptors Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing incidence of cancer is anticipated to serve as a significant catalyst for the expansion of the G-protein-coupled receptors market in the foreseeable future. Cancer, characterized by the uncontrolled proliferation and invasion of abnormal cells into adjacent tissues, often spreads via the body’s lymphatic and vascular networks. G-protein-coupled receptors play a crucial role in regulating the very hallmarks of cancer, encompassing proliferative signaling, sustained replicative capacity, evasion of growth inhibitory signals, resistance to programmed cell death (apoptosis), and the promotion of invasion and metastasis. Illustrating this trend, the American Cancer Society, a prominent professional organization in the United States, estimated in January 2023 that approximately 1,958,310 new cancer diagnoses would occur in the US during 2023, a rise from the roughly 1.9 million cases identified in 2022. Consequently, the escalating burden of cancer is directly fueling the advancement of the G-protein-coupled receptors market.
G-Protein Coupled Receptors Market Segment Analysis Highlighting Growth Areas
The g-protein coupled receptors market covered in this report is segmented –
1) By Product: Cell Lines, Detection Kits, Cell Culture Reagents, Ligands
2) By Assay: CAMP Functional Assays, Calcium Functional Assays, ß-Arrestin Functional Assays, Radioligand Binding And GTP?S Functional Assays, Internalization Assays, Trafficking Assays
3) By Applications: Cancer Research, CNS Research, Metabolic Research, Cardiovascular Research, Inflammation Research, Respiratory Research, Other Applications
Subsegments:
1) By Cell Lines: GPCR-Expressing Cell Lines, Stable And Transient Cell Lines
2) By Detection Kits: ELISA Kits, High-Throughput Screening Kits, Reporter Gene Assays
3) By Cell Culture Reagents: Media And Supplements, Transfection Reagents, Growth Factors
4) By Ligands: Agonists, Antagonists, Inverse Agonists
G-Protein Coupled Receptors Market Trends: What Is Shaping Future Industry Growth?
Companies at the forefront of the G-protein coupled receptors sector are currently undertaking Initial Public Offerings (IPOs) with the explicit goal of advancing drug development initiatives centered on G protein-coupled receptors (GPCRs). This strategic financial maneuver is designed to expedite research and development pipelines, propel clinical trials forward, and ultimately introduce novel therapeutic solutions for a spectrum of ailments, encompassing oncological, neurological, and metabolic diseases. The capital infusion garnered is predominantly allocated to fuel the progression of their principal product candidates aimed at addressing chronic metabolic and pulmonary conditions. A key allocation of these funds will be directed towards the enhancement of their glucagon-like peptide-1 receptor (GLP-1R) agonist program, which endeavors to provide treatments for diabetes and obesity. Illustrating this trend, Structure Therapeutics Inc., an entity based in the United States, successfully concluded its IPO in February 2023, securing $161 million. This funding will be instrumental in propelling their development of therapeutics derived from G-protein coupled receptor (GPCR) platforms. The company issued 10,740,000 American depositary shares (ADSs) at a price of $15.00 per ADS, a figure that notably exceeded their initial forecasts. These shares commenced trading on the Nasdaq Global Market, identified by the ticker symbol ‘GPCR’.
G-Protein Coupled Receptors Market Leading Companies: Who Holds Significant Market Presence?
Major companies operating in the g-protein coupled receptors market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca Plc, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Boehringer Ingelheim, Daiichi Sankyo Company Limited, Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Bio-Techne Corporation, Abcam PLC, Cara Therapeutics Inc., Sosei Heptares Ltd., Eurofins DiscoverX Corporation, Crinetics Pharmaceuticals Inc., Domain Therapeutics SA, Addex Pharmaceuticals Ltd., Structure Therapeutics, Septerna
Access The Complete G-Protein Coupled Receptors Market Report:
https://www.thebusinessresearchcompany.com/report/g-protein-coupled-receptors-global-market-report
G-Protein Coupled Receptors Market Regional Outlook: Where Are The Largest Opportunities Located?
North America was the largest region in the G-protein coupled receptors market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the g-protein coupled receptors market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
